Antibacterial and antitubercular activity of fosmidomycin, FR900098, and their lipophilic analogs.
about
Prodrugs of phosphonates and phosphates: crossing the membrane barrierAlteration of the Flexible Loop in 1-Deoxy- d -xylulose-5-phosphate Reductoisomerase Boosts Enthalpy-Driven Inhibition by FosmidomycinLipophilic prodrugs of FR900098 are antimicrobial against Francisella novicida in vivo and in vitro and show GlpT independent efficacyKinetic characterization and allosteric inhibition of the Yersinia pestis 1-deoxy-D-xylulose 5-phosphate reductoisomerase (MEP synthase)The mycobacterial cell envelope-lipidsThe cell envelope glycoconjugates of Mycobacterium tuberculosisResistance of Francisella novicida to fosmidomycin associated with mutations in the glycerol-3-phosphate transporter.Molecular Basis for Resistance Against Phosphonate Antibiotics and Herbicides.Design of Potential Bisubstrate Inhibitors against Mycobacterium tuberculosis (Mtb) 1-Deoxy-D-Xylulose 5-Phosphate Reductoisomerase (Dxr)-Evidence of a Novel Binding Mode.Progress in targeting cell envelope biogenesis in Mycobacterium tuberculosis.The effect of chain length and unsaturation on Mtb Dxr inhibition and antitubercular killing activity of FR900098 analogs.Viable screening targets related to the bacterial cell wall.MEPicides: potent antimalarial prodrugs targeting isoprenoid biosynthesis.Structure-Activity Relationships of the MEPicides: N-Acyl and O-Linked Analogs of FR900098 as Inhibitors of Dxr from Mycobacterium tuberculosis and Yersinia pestis.Growth medium-dependent antimicrobial activity of early stage MEP pathway inhibitors.Acyloxybenzyl and Alkoxyalkyl Prodrugs of a Fosmidomycin Surrogate as Antimalarial and Antitubercular Agents
P2860
Q27005712-79B38D00-7D42-401E-AB90-B07C5D43E3D5Q27683779-5FA8B3A3-7E8B-47B0-828F-80C266D8021AQ28484402-09694004-FB3D-4C6A-B2C0-34BD8BA5BFE8Q28542677-75A0DC11-BF97-48F2-B120-E7C5A2DDD0F9Q34355375-881CDD37-8D09-482D-999A-D3BF7CC55552Q34423962-55BB593C-32EE-4900-8633-37FC6B78919BQ36159482-A9D54573-8FD7-4D84-8F75-74A8EC1C47C1Q36490822-600080EE-7775-4F59-B41F-CE9B03DD3A16Q37063813-A6922CCC-3EA9-4606-BBCD-6ECA95E60618Q37403156-BF8DBF81-9A4A-47D4-B2A3-021E6F5EA788Q37590304-FA391D82-16DA-4648-BDF9-03AA386E8976Q38070780-BBE68A5A-A69A-4992-B438-73BCEAAC89E7Q38615212-FD88AC05-720B-4E05-A398-A131859CC022Q38817206-E8D8D0F0-EDD3-45A8-A78D-D1F03318E695Q55093817-D7A2DFEA-608C-4D3F-9D39-91C9D1062C92Q57822338-EBF10E67-E6D2-479B-A84D-6D207A188D9D
P2860
Antibacterial and antitubercular activity of fosmidomycin, FR900098, and their lipophilic analogs.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Antibacterial and antitubercul ...... and their lipophilic analogs.
@ast
Antibacterial and antitubercul ...... and their lipophilic analogs.
@en
type
label
Antibacterial and antitubercul ...... and their lipophilic analogs.
@ast
Antibacterial and antitubercul ...... and their lipophilic analogs.
@en
prefLabel
Antibacterial and antitubercul ...... and their lipophilic analogs.
@ast
Antibacterial and antitubercul ...... and their lipophilic analogs.
@en
P2093
P2860
P1476
Antibacterial and antitubercul ...... and their lipophilic analogs.
@en
P2093
Cynthia S Dowd
Emily R Jackson
Géraldine San Jose
Helena I Boshoff
Marcus Maddox
Robin E Lee
P2860
P304
P356
10.1016/J.BMCL.2011.09.123
P407
P50
P577
2011-10-05T00:00:00Z